# A Promising Tool for Predicting Consciousness Evolution in Prolonged Disorders of Consciousness

> **NCT02948660** · PHASE2 · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 36 (actual)

## Conditions studied

- Disorder of Consciousness

## Interventions

- **DRUG:** Zolpidem Tartrate Tablets

## Key facts

- **NCT ID:** NCT02948660
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-06-30
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2022-05-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02948660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02948660, "A Promising Tool for Predicting Consciousness Evolution in Prolonged Disorders of Consciousness". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02948660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
